Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.

Ismail KocyiğitFahir OzturkEray ErogluZuleyha KaracaAhmet Safa KaynarMustafa CetinBulent TokgozMurat Hayri SipahiogluRuslan BayramovAhmet SenOktay OymakTevfik EcderJonas Axelsson

Published in: Clinical and experimental nephrology (2019)

Our data supports the notion that dysmetabolisms part of the ADPKD phenotype and associated with a poor outcome, especially in patients with a truncating PKD1 mutation.

Keyphrases

polycystic kidney disease
electronic health record
big data
type diabetes
machine learning
adipose tissue
glycemic control
skeletal muscle